• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

住院患儿中由耐碳青霉烯类革兰氏阴性病原体引起的感染。

Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.

机构信息

Department for Interventions in Health-Care Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece.

出版信息

Pediatr Infect Dis J. 2013 Apr;32(4):e151-4. doi: 10.1097/INF.0b013e3182804b49.

DOI:10.1097/INF.0b013e3182804b49
PMID:23249908
Abstract

BACKGROUND

Carbapenem-resistant Gram-negative pathogens (CRPs) are emerging as major causes of nosocomial infections that increase morbidity, mortality and healthcare costs. Little is known about CRP infections in children.

METHODS

All newly detected infections caused by carbapenem-resistant Klebsiella spp, Pseudomonas spp or Acinetabocater spp in hospitalized patients are prospectively reported to the Hellenic Center for Disease Control and Prevention. All children <15 years old with a CRP infection reported from November 1, 2010, through March 30, 2012, were included in this study.

RESULTS

Between November 2010 and March 2012, 71 CRP infections in 65 children (median age: 1 year) were reported. Underlying conditions existed in 50 (76.9%) children. Cases included pneumonia (25 [35.2%], including 20 ventilator-associated pneumonias), bacteremia (32.4%), urinary tract infection (19.7%) and surgical site infection (12.7%). Isolates were Pseudomonas spp (41.1%), Acinetobacter spp (39.7%) and Klebsiella spp (19.2%). The first positive culture occurred a median of 20 days (range: 0-313 days) after admission. Twenty-four (33.8%) infections occurred in patients with a history of hospitalization the previous 6 months; 42 (59.2%) and 36 (50.7%) infections occurred among patients who had received broad-spectrum antibiotics including carbapenems the previous 6 months, respectively. The crude mortality at 28 days after the first positive CRP culture was 21.1%.

CONCLUSIONS

Infections caused by CRPs among children are associated with significant morbidity and mortality.

摘要

背景

耐碳青霉烯类革兰氏阴性病原体(CRPs)正在成为导致医院感染的主要原因,这些感染会增加发病率、死亡率和医疗保健成本。关于儿童中 CRP 感染的信息知之甚少。

方法

所有新发现的住院患者中由耐碳青霉烯类肺炎克雷伯菌、铜绿假单胞菌或鲍曼不动杆菌引起的感染均由希腊疾病控制和预防中心前瞻性报告。2010 年 11 月 1 日至 2012 年 3 月 30 日期间报告的所有 15 岁以下儿童耐碳青霉烯类 CRP 感染患者均纳入本研究。

结果

2010 年 11 月至 2012 年 3 月期间,共报告 65 例儿童(中位年龄:1 岁)中 71 例 CRP 感染病例。50 例(76.9%)儿童存在基础疾病。病例包括肺炎(25 例[35.2%],包括 20 例呼吸机相关性肺炎)、菌血症(32.4%)、尿路感染(19.7%)和手术部位感染(12.7%)。分离株为铜绿假单胞菌(41.1%)、鲍曼不动杆菌(39.7%)和肺炎克雷伯菌(19.2%)。首次阳性培养中位数发生在入院后 20 天(范围:0-313 天)。24 例(33.8%)感染发生在过去 6 个月有住院史的患者中;42 例(59.2%)和 36 例(50.7%)感染分别发生在过去 6 个月接受包括碳青霉烯类药物在内的广谱抗生素治疗的患者中。首次 CRP 阳性培养后 28 天的粗死亡率为 21.1%。

结论

儿童中由 CRPs 引起的感染与较高的发病率和死亡率相关。

相似文献

1
Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.住院患儿中由耐碳青霉烯类革兰氏阴性病原体引起的感染。
Pediatr Infect Dis J. 2013 Apr;32(4):e151-4. doi: 10.1097/INF.0b013e3182804b49.
2
How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.耐碳青霉烯类不动杆菌属细菌如何在新建医院中定殖。
Int J Antimicrob Agents. 2008 May;31(5):463-6. doi: 10.1016/j.ijantimicag.2008.01.019. Epub 2008 Mar 24.
3
Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.1994 - 2012年瑞典烧伤中心抗生素敏感性监测
Burns. 2016 Sep;42(6):1295-303. doi: 10.1016/j.burns.2016.01.025. Epub 2016 May 27.
4
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.氨苄西林/舒巴坦与多黏菌素治疗耐碳青霉烯类不动杆菌属所致感染的比较
J Antimicrob Chemother. 2008 Jun;61(6):1369-75. doi: 10.1093/jac/dkn128. Epub 2008 Mar 25.
5
Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: sensitivity to antibiotics and risk factors.医院获得性铜绿假单胞菌和不动杆菌属引起的尿路感染:抗生素敏感性和危险因素。
Am J Infect Control. 2013 Dec;41(12):1182-7. doi: 10.1016/j.ajic.2013.02.018. Epub 2013 May 29.
6
Emergence of carbapenem-resistant Klebsiella spp. infections in a Turkish university hospital: epidemiology and risk factors.土耳其一家大学医院中耐碳青霉烯类克雷伯菌属感染的出现:流行病学及危险因素
J Infect Dev Ctries. 2014 Jan 15;8(1):44-9. doi: 10.3855/jidc.3091.
7
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.危重症患者医院获得性多重耐药革兰阴性杆菌感染的预测工具——前瞻性观察性研究
BMC Infect Dis. 2014 Nov 25;14:615. doi: 10.1186/s12879-014-0615-z.
8
Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.耐碳青霉烯类不动杆菌感染患者的危险因素及结局
Scand J Infect Dis. 2013 Mar;45(3):213-8. doi: 10.3109/00365548.2012.724178. Epub 2012 Oct 31.
9
Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.快速诊断与抗菌药物管理的整合可改善抗生素耐药革兰氏阴性菌血症患者的结局。
J Infect. 2014 Sep;69(3):216-25. doi: 10.1016/j.jinf.2014.05.005. Epub 2014 May 17.
10
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.中性粒细胞减少患者中碳青霉烯类耐药的全球患病率及其与死亡率和碳青霉烯类使用的关联:系统评价和荟萃分析
J Antimicrob Chemother. 2017 Mar 1;72(3):668-677. doi: 10.1093/jac/dkw459.

引用本文的文献

1
Microbiological Characteristics, Risk Factors, and Short-Term Mortality of Carbapenem-Resistant Bloodstream Infections in Pediatric Patients in China: A 10-Year Longitudinal Study.中国儿童患者耐碳青霉烯类血流感染的微生物学特征、危险因素及短期死亡率:一项10年纵向研究
Infect Drug Resist. 2024 Nov 2;17:4815-4823. doi: 10.2147/IDR.S485001. eCollection 2024.
2
Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a tertiary university hospital.碳青霉烯类耐药肠杆菌科细菌血流感染患儿的临床结局及治疗方式的影响:一项来自三级大学医院的回顾性队列研究
J Antimicrob Chemother. 2025 Jan 3;80(1):147-153. doi: 10.1093/jac/dkae387.
3
Clinical experience with ceftazidime/avibactam for the treatment of extensively drug-resistant or pandrug-resistant Klebsiella pneumoniae in neonates and children.治疗新生儿和儿童广泛耐药或全耐药肺炎克雷伯菌的头孢他啶/阿维巴坦的临床经验。
Eur J Clin Microbiol Infect Dis. 2024 Dec;43(12):2361-2369. doi: 10.1007/s10096-024-04948-y. Epub 2024 Oct 1.
4
Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study.头孢他啶-阿维巴坦用于儿童疑似或确诊耐碳青霉烯类微生物感染的回顾性研究。
Infect Drug Resist. 2023 Sep 5;16:5815-5824. doi: 10.2147/IDR.S426326. eCollection 2023.
5
The Prevalence of Carbapenemase-Producing Microorganisms and Use of Novel Cephalosporins for the Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria in a Pediatric Cardiac Intensive Care Unit.儿科心脏重症监护病房中产碳青霉烯酶微生物的流行情况以及新型头孢菌素用于治疗耐碳青霉烯革兰氏阴性菌引起的严重感染的情况
Antibiotics (Basel). 2023 Apr 22;12(5):796. doi: 10.3390/antibiotics12050796.
6
Molecular Hybrids of Pyazolo[3,4-]pyridine and Triazole: Design, Synthesis and In Vitro Antibacterial Studies.吡唑并[3,4-]吡啶和三唑的分子杂合体:设计、合成与体外抗菌研究。
Molecules. 2022 Nov 7;27(21):7647. doi: 10.3390/molecules27217647.
7
Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.耐头孢他啶-阿维巴坦的肺炎克雷伯菌碳青霉烯酶变异体:进化概述。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0044722. doi: 10.1128/aac.00447-22. Epub 2022 Aug 18.
8
Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.儿童耐碳青霉烯类革兰氏阴性菌感染。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.02183-19.
9
Running out of options: Extensively drug-resistant urinary tract infection in an infant.无计可施:一名婴儿的广泛耐药性尿路感染
Paediatr Child Health. 2019 Sep;24(6):371-373. doi: 10.1093/pch/pxz048. Epub 2019 Apr 9.
10
Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.儿童血流感染碳青霉烯类耐药肺炎克雷伯菌的危险因素及病死率的预测因素。
BMC Infect Dis. 2018 May 31;18(1):248. doi: 10.1186/s12879-018-3160-3.